PacBio Unveils a New Method for Comprehensive, Genome-wide Tandem Repeat AnalysisAnalysis Method Supports Research on the Genetic Causes of Common Diseases PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of a new computation.
/PRNewswire/ PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of a new.
Analysis Method Supports Research on the Genetic Causes of Common Diseases
MENLO PARK, Calif., Sept. 27, 2022 /PRNewswire/ PacBio , a leading developer of high-quality, highly accurate.